home / stock / txg / txg news


TXG News and Press, 10x Genomics Inc. From 11/01/23

Stock Information

Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NYSE
Website: 10xgenomics.com

Menu

TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...

TXG - 10x Genomics to Present at the Stephens 25th Annual Conference

10x Genomics to Present at the Stephens 25th Annual Conference PR Newswire PLEASANTON, Calif. , Nov. 1, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will pa...

TXG - Torex Gold Provides Quarterly Update on Media Luna Project

(All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) provides Q3 2023 update on the development of its Media Luna Project (“Media Lunaȁ...

TXG - Revvity's disappointing Q3 report weighs on life sciences tool stocks

2023-10-30 12:28:25 ET More on Revvity Revvity: Recent Investments, Acquisitions, Not Pulling Economic Weight (Rating Downgrade) Revvity, Inc. (RVTY) Q2 2023 Earnings Call Transcript Revvity, Inc. 2023 Q2 - Results - Earnings Call Presentation Revvity misses ...

TXG - Canaccord sees solid Q3 earnings for medtech; likes Quanterix, Natera, Guardant

2023-10-29 17:28:12 ET More on Guardant Health, Natera, etc. Natera: Cash Burn Remains A Concern Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Mar...

TXG - Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors

Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model of Lethal Pediatric Brain Tumors PR Newswire S cientific pre-print featuring customer-generated data demonstrates the power of single cell spatial analysis to more directly assess unique tissue micro...

TXG - Torex Gold Reports Q3 2023 Production Results

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) reports Q3 2023 gold production of 85,360 ounces (“oz”) and gold sold of 81,752 oz. With year-to-date gold production of 315,785 oz and the fourth q...

TXG - 10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023

10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023 PR Newswire PLEASANTON, Calif. , Oct. 11, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report f...

TXG - 10x Genomics Comments on Second UPC Preliminary Injunction Decision

10x Genomics Comments on Second UPC Preliminary Injunction Decision PR Newswire UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect PLEASANTON, Calif. , Oct. 10, 2023 /PRN...

TXG - 10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe PR Newswire Second Injunction Issued Against CosMx PLEASANTON, Calif. , Sept. 19, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader ...

TXG - NanoString falls amid report of prelim injunction in Germany in dispute with 10x Genomics

2023-09-19 10:11:41 ET More on NanoString, 10x Genomics Seeking Alpha’s Quant Rating on NanoString 10x Genomics: Recent Performance Amplifies My Bullish Conviction NanoString gains amid new counterclaims in patent dispute with 10x Genomics NanoString T...

Previous 10 Next 10